NSCLC Harboring NRG1 Fusion
2 clinical trials · Condition
◉ Watch NSCLC Harboring NRG1 Fusion
| Record | Firm | Date |
|---|---|---|
| A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) (NCT02912949) | Partner Therapeutics, Inc. | 2015-01-01 |
Track NSCLC Harboring NRG1 Fusion automatically
Every clearance here is in the API, with alerts when new ones post.